Disclosure Of Intangible Assets [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of intangible assets [text block]
Research and development expense
16 062 NOK
15 627 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.